Taurel says Lilly will boost Cymbalta advertising

Share this article:
Lilly chief Sidney Taurel told Reuters the company would boost consumer advertising for Cymbalta as the firm seeks additional indications on the drug, including chronic pain, in the US and launches it in new markets abroad.

This material may not be published, broadcast, rewritten or redistributed in any form without prior authorization. Your use of this website constitutes acceptance of Haymarket Media's Privacy Policy and Terms & Conditions